Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.
Take Your Trading To The Next Level. Get Started Here!
Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.
Mattel reported earnings and revenue that came in higher than Wall Street's expectations.
A tentative agreement could be announced as early as Wednesday night, pending approval of local UAW leaders, sources told CNBC.
X’s new gaming feature, exclusive Q&A with Cronos Labs’ Ella Qiang, Immutable’s cloud titan partner.
Meta finance chief Susan Li told analysts on the company's earnings call that volatility in the Middle East is creating some revenue uncertainty
Gross domestic product, or the sum of all goods and services produced in the U.S. economy, is expected to post a 4.7% annualized gain for the third quarter.
Asset manager Hashdex recently met with the U.S. SEC to address the regulator’s concerns over its application for a spot Bitcoin ETF.
Rocket Lab is in the final stages of closing an investigation into its most recent Electron launch, which failed midflight in September.
President Joe Biden Wednesday stressed the conflict spanning Israel and Gaza must end with a vision of a "two-state solution."